News
Max July 2023 Releases
Max’s July 2023 schedule is filled with exciting releases, from dramas to documentaries. Here are some titles that we think you’ll enjoy. “Full ...
News
FibroGen Shares Plummet After Trial Misses Endpoint
By Chris Wack FibroGen’s shares have dropped significantly after the company reported that its recent trial for pamrevlumab has failed to meet its ...
News
Selling Your Inherited House
As the trustee for your mother’s revocable trust, you’re planning to sell her house and distribute the proceeds after her passing. Your younger ...
News
Eupraxia Pharmaceuticals Hits Targets for EP-104IAR
Canadian biotechnology company, Eupraxia Pharmaceuticals, announced on Monday that it will move ahead with its late-stage development program after successfully achieving key targets ...
News
The Elongated Economic Cycle
The COVID-19 pandemic brought the global economy to an abrupt halt in 2020. China, the epicenter of the outbreak, took the unprecedented step ...
News
Pfizer’s Danuglipron for Obesity and Type 2 Diabetes
Pfizer Inc. has announced plans to focus on developing its oral candidate danuglipron as a treatment for obesity and type 2 diabetes. This ...
News
LL Flooring Rejects Buyout Bid
Shares of LL Flooring Holdings Inc. (LL) surged 4.7% in premarket trading on Monday after the company announced that it has turned down ...
News
U.S. Stock Futures Dip as Russia Uncertainty Weighs
U.S. stock futures edged lower on Monday, continuing last week’s dip as uncertainty surrounding Russia induced investors to seek safe assets such as ...
News
Mixed Results for Asia-Pacific Stocks
Asia-Pacific stocks experienced a mixed start to the week on Monday, June 26. The Hong Kong market saw its fifth consecutive day of ...